An indolent B-cell lymphoma with t(2;8)(p12;q24) abnormality and absence of C-MYC amplification and TP53 deletion.: A new variant?

被引:2
|
作者
Potti, A
Panwalkar, A
Ingebretson, MC
Tharapel, SA
Goodell, M
Dayton, MV
Mehdi, SA
机构
[1] Univ N Dakota, Sch Med, Vet Affairs Med Ctr, Div Hematol Oncol, Fargo, ND 58102 USA
[2] Univ N Dakota, Sch Med, Dept Med, Fargo, ND USA
[3] Vet Affairs Med Ctr, Dept Pathol, Cytogenet Reference Lab, Memphis, TN USA
[4] Univ Minnesota, Dept Hematopathol, Minneapolis, MN USA
关键词
D O I
10.1016/S0165-4608(02)00931-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The translocation between chromosomes 2 and 8, t(2;8), is well known for its strong association with high-grade Burkitt lymphoma. However, the significance of this translocation in indolent lymphoproliferative disorders is not clear. We present the case of a 75-year-old white male with left upper quadrant abdominal pain, splenomegaly, and an elevated white cell count of 30.3 x 10(9) cells/L (84% large lymphoid cells with scanty cytoplasm and prominent central nucleoli). Immunophenotyping revealed a clonal B-cell population coexpressing CD5, CD19, and CD20 with weak CD23 and CD25 and very weak, restricted, surface lambda. The cytogenetic analysis showed all 20 cells with t(2;8)(p12;q24.3). In addition, four of the 20 cells also showed a second translocation: t(12;17)(p13;q21). Molecular analysis using c-myc and p53 probes showed normal results with no indication of amplification of C-MYC or deletion of TP53. The patient was managed as an indolent/low-grade lymphoproliferative disorder with excellent response to eight cycles of fludarabine. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:76 / 79
页数:4
相关论文
共 40 条
  • [21] The prognostic role of Bcl-2, Ki67, c-MYC and p53 in diffuse large B-cell lymphoma
    Patrascu, Ana-Maria
    Rotaru, Ionela
    Olar, Lavinia
    Patrascu, Stefan
    Ghilusi, Mirela-Corina
    Neamtu, Simona-Daniela
    Nacea, Janina Georgiana
    Gluhovschi, Adrian
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2017, 58 (03): : 837 - 843
  • [22] Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8;14)(q24;q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus
    Stejskalova, Eva
    Jarosova, Marie
    Kabickova, Edita
    Smelhaus, Vratislav
    Mrhalova, Marcela
    Kodet, Roman
    CANCER GENETICS AND CYTOGENETICS, 2006, 170 (02) : 158 - 162
  • [23] MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
    Wang, Jiachen
    Shang, Zhen
    Wang, Jue
    Xu, Jinhuan
    Li, Weigang
    Guan, Yuqi
    Yang, Li
    Zhang, Wei
    Shen, Kefeng
    Zhang, Meilan
    Wang, Jin
    Chen, Liting
    Li, Qinlu
    He, Cheng
    Wang, Na
    Huang, Liang
    Xiao, Yi
    Xiao, Min
    Zhou, Jianfeng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (06)
  • [24] Richter's transformation of a B cell non Hodgkin lymphoma of the subtype chronic lymphatic leukemia with aberrant MYC/IGH t(8;14) translocation and 17p(TP53) deletion: A case report
    Drechsler, S.
    Arndt, N.
    Neumann, K.
    Rebmann, U.
    Florschuetz, A.
    Knolle, J.
    VIRCHOWS ARCHIV, 2017, 471 : S145 - S145
  • [25] Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma
    Kayo Takeoka
    Miho Nakagawa
    Chiyuki Kishimori
    Katsuhiro Fukutsuka
    Fumiyo Maekawa
    Masahiko Hayashida
    Hitoshi Ohno
    Annals of Hematology, 2021, 100 : 3043 - 3045
  • [26] Coexistence of MYC/BCL2 double-hit of t(8;14)(q24;q32) and t(14;18)(q32;q21) and that of t(8;22)(q24;q11) and t(14;18) in advanced-stage high-grade B cell lymphoma
    Takeoka, Kayo
    Nakagawa, Miho
    Kishimori, Chiyuki
    Fukutsuka, Katsuhiro
    Maekawa, Fumiyo
    Hayashida, Masahiko
    Ohno, Hitoshi
    ANNALS OF HEMATOLOGY, 2021, 100 (12) : 3043 - 3045
  • [27] Fludarabine/Rituximab-Induced cytogenetic remission in a patient with B-cell prolymphocytic leukemia bearing Burkitt's variant translocation t(2;8)(p12;q24.1).
    Lazo-Langner, A
    Lome-Maldonado, C
    Piedras, J
    Gaulard, P
    Quintanilla-Martínez, L
    López-Karpovitch, X
    BLOOD, 2002, 100 (11) : 364B - 364B
  • [28] Expression of ice, bcl-2, c-myc and p53 in different bone marrow cell populations from patients with diffuse large B-cell lymphoma
    Madrigal-Velázquez, M
    Avilés, A
    Neri, N
    Huerta, J
    Martínez-Jaramillo, G
    Mayani, H
    LEUKEMIA & LYMPHOMA, 2006, 47 (04) : 665 - 673
  • [29] A Double Hit CD10-Negative B-Cell Lymphoma with t(3;8)(q27;q24) Leading to Juxtaposition of the BCL6 and MYC Loci Associated with Good Clinical Outcome
    Sanders, Lucinda
    Jayne, Sandrine
    Kennedy, Ben
    Miall, Fiona
    Aukema, Sietse M.
    Siebert, Reiner
    Wagner, Simon D.
    Dyer, Martin J. S.
    CASE REPORTS IN HEMATOLOGY, 2014, 2014
  • [30] c-MYC, RB-1, TP53, and centromere 8 and 17 copy number in B-cell non-Hodgkin's lymphomas assessed by dual-color fluorescence in situ hybridization
    Galteland, E
    Holte, H
    Stokke, T
    CYTOMETRY, 1999, 38 (02): : 53 - 60